Navigation Links
China-Biotics, Inc. Reports Record Quarterly and Annual Revenue Growth for Fiscal Year 2010
Date:6/13/2010

the retail probiotics market while our diversifying product portfolio is attracting different customer groups. The long-term growth prospect of retail probiotics products in China is promising as more and more Chinese become aware of the benefit of probiotics to enhance their health condition. Therefore, our current business lines continued to generate record growth momentum.

"More excitingly, our new bulk additive line quickly expanded to account for 26.8% of annual revenue in fiscal year 2010, an increase from 8.3% in fiscal year 2009. We expect the application of bulk additive probiotics in dairy and animal feed products to grow robustly in the future. The Chinese yogurt market is quickly embracing probiotics and the market potential is large. We remain confident that the addition of the bulk franchise will become the engine to drive our growth from both near-term and long-term perspectives. We look forward to becoming the dominant provider of bulk probiotics products in China and creating our long-term shareholder value."

Fourth Quarter FY2010 Financial Results

Revenues in the fourth quarter of fiscal year 2010 increased to $25.5 million from $15.5 million in the fourth quarter of fiscal year 2009. The increase was primarily due to increased sales volume in retail and bulk additive products, and bulk additive products increasingly account for a larger share of total revenue.

Gross profit increased 66.5% to $17.7 million from $10.6 million in the same period of fiscal year 2009. Gross margin was 69.4% compared with 68.5% in the same period of fiscal year 2009. The improvement in gross margin was mainly attributable to a product mix c
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
2. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
3. China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
4. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter Fiscal 2010 Financial Results
5. China-Biotics, Inc. Appoints New Vice President
6. China-Biotics, Inc. to Attend the SIG 3rd Annual Beijing Management Summit
7. China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results
8. China-Biotics, Inc. Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate
9. China-Biotics, Inc. Applies for Four Patents on Probiotic Formulations
10. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
11. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 Today BioSpace , the leading life sciences ... campaign spotlighting the life sciences community in Illinois , ... Kansas , Michigan , Minnesota ... Ohio and Wisconsin . ... of all job postings on BioSpace originating in this region in 2013. ...
(Date:7/31/2014)... for a number of breakthroughs, which altered the course ... paper, which laid the foundation of computer science, providing ... next played a pivotal role in the Second World ... codes, enabling the Allies to defeat the Nazis in ... turned his attention to artificial intelligence and proposed a ...
(Date:7/31/2014)... Ind. -- Chemists at Indiana University Bloomington have ... bricks-and-mortar fashion, a development with potential value for ... field-effect transistors and photovoltaic cells. , Their paper, ... Crystalline Solids and 2D Self-Assembled Crystals," has been ... journal of the Royal Society of Chemistry. It ...
(Date:7/31/2014)... VALLEY, Calif. , July 31, 2014 ... San Francisco Bay Area , has acquired ... University of Oxford,s commercialisation company. The potent anti-inflammatory activity ... Greaves at the University of Oxford,s Sir ... The company, which has raised over $1.5 million in ...
Breaking Biology Technology:Midwest Biotech Leaders Featured On BioSpace Map 2A mathematical theory proposed by Alan Turing in 1952 can explain the formation of fingers 2A mathematical theory proposed by Alan Turing in 1952 can explain the formation of fingers 3Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3
... Inc., a privately-,held, specialty pharmaceutical company, announced today ... financing, which included investors Domain Associates,Latterell Venture Partners ... committed to the development of prescription,products based on ... unmet,needs of patients and their caregivers. Meritage Pharma,s ...
... and existing antibiotics to create a broad offering of ... ... LONDON, June 16 Mpex Pharmaceuticals and,GlaxoSmithKline (GSK) today announced ... discovery, development and,commercialization of novel medicines for bacterial diseases. The,collaboration ...
... Medullary Thyroid Cancer Planned to Initiate This Summer, ... Inc. (Nasdaq: EXEL ) announced today that ... (FDA) have reached agreement on the phase 3,registration ... targeting,MET, RET, and VEGFR2, via the Special Protocol ...
Cached Biology Technology:Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing 2GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 2GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 3GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 4GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 5Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 2Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 3Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 4Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 5
(Date:7/31/2014)... Oren Tessler, Assistant Professor of Clinical Surgery at LSU ... part of a team of plastic and reconstructive surgeons ... to screen and select patients for a specific surgical ... who underwent this surgery to decompress the nerves that ... cosmetic eyelid surgery. The study, which confirms the benefit ...
(Date:7/31/2014)... Biometrics industry sees growth as ... companies turn towards digital currency: NXT-ID, Inc. (OTCBB: NXTD), ... (NASDAQ: AMZN ), Facebook Inc. (NASDAQ: ... ) and Microsoft Corporation (NASDAQ: MSFT) NXT-ID, Inc., ... m-commerce market, announces a video featuring its next generation ...
(Date:7/30/2014)... paving the way for a breakthrough that may ... exposed to poisonous chemicalsparticularly those in pesticides and ... current issue of the journal ChemBioChem ... compounds commonly used in pesticides and warfare agents. ... of Engineering Associate Professor of Chemical and Biological ...
Breaking Biology News(10 mins):Surgeons report significant migraine relief from cosmetic eyelid surgery technique 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 3Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 4Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 5Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 6Engineering a protein to prevent brain damage from toxic agents 2
... 6, 2013  Daniel P. Linskey, superintendent-in-chief of the Boston ... Marathon Bombings" at the 2013 IEEE International Conference on Technologies ... Linskey,s talk will focus on the aftermath of the tragic ... department and federal enforcement agencies that ultimately led to the ...
... in the early 1990s, the protein STAT1 (Signal Transducer ... be central in passing signals across immune cells, ensuring ... from viruses or other pathogens. Animals without STAT1 are ... somehow involved in protection against malignant cells. The STAT1 ...
... To protect consumers, screening shellfish for fungal toxins is ... September) in the Society for Applied Microbiology (SfAM) journal, ... an area with contamination by strains of Penicillium ... will contain toxins at much higher levels that are ...
Cached Biology News:Boston Police Chief to Address Boston Marathon Bombings at IEEE Homeland Security Conference in Waltham, Mass., on 12 November 2Static killers? 2
Request Info...
supplied with 10x reaction buffer...
... ATP: D-hexose 6- phosphotransferase/D-glucose-6-phosphate: NADP ... of HK will phosphorylate 1 ... min at 25C at pH ... will oxidize 1 mol of ...
Request Info...
Biology Products: